Updated 04:19 GMT, 17 Nov 2026 SPX 7,416.59 -1.92% NDX 27,197.15 -2.67% VIX 22.91 +18.70% GOLD 3,872.70 -0.35% CL 84.95 -4.08% BTC 64,888.19 -0.64%
NAS100 27,197 −2.67% S&P 7,417 −1.92% GOLD $3,873 −0.35% BTC $64,888 −0.64% VIX 22.91 +18.70% latest tape · as of 04:19 UTC
The Screen · Consumer Defensive · Confectioners

Hershey Company (The)

HSY · a US exchange · USD · Market cap $35.0B · 17,550 employees

The Hershey Company, together with its subsidiaries, engages in the manufacture and sale of confectionery products and pantry items in the United States and internationally.

FAIL · Does not pass the screen
174.27 USD

Price as of 13 Nov 2026Daily close, not a live quoteLast reviewed 4 days ago

Screened 2026-11-13 · the tape above runs as of 04:19 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed

Key facts today

  • Price174.27 USD at the 13 Nov 2026 close
  • Our value readOvervalued vs our fair value, as of 13 Nov 2026
  • Our regime readMarkup, as of 15 Nov 2026
  • Ethical screenDoes not pass
  • OptionsOpen interest leans heavily to calls (put/call 0.66)
  • Last reviewed13 Nov 2026 (4 days ago)
  • Release timesRelease and earnings times on your chart: Event Guard Mentor

A summary of the dated readings below, not a live quote and not advice.

PRICE · ONE YEAR

Our fair-value range: $138.60 to $170.62, base estimate $148.37 (screen dated 2026-11-13).

Current read
Markup ?
Overvalued · screened 2026-11-13
  • Trend Markup
  • Insiders insiders sold, $3,264,345, latest filing 2026-10-29
  • Positioning political selling, disclosed 2026-10-07
  • Options put/call open interest 0.66, read 2026-11-14
  • Ethical does not pass the values gate
Price174.27 USD
Fair value148.37
Ethical score10.0/100
Value readOvervaluedas of 13 Nov 2026
Our investment reviews on this name
2026-10-26Read Markup168.68+3.3% to today ✓Accumulation gives way to Markup first Markup read since July
2026-10-21Read Accumulation168.68+3.3% to today ✓Markdown gives way to Accumulation
2026-10-02Read Markdown164.41+6.0% to today Accumulation gives way to Markdown after a 12% slide in 4 weeks
2026-09-01Read Accumulation186.46-6.5% to today Distribution gives way to Accumulation

Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.

The full research record, in depth, below
The Label · The Season, Not the Day

This name holds its markup label.

Hershey Company (The) holds its Markup at $174.27. Consolidating, no directional conviction, held for 61 days.

As held on the ledger · 2026-11-13
PhaseMarkup
Quantitative stateConsolidating, no directional conviction, held for 61 days
Price at the screen$174.27
Valuation19.68 trailing · 18.35 forward price to earnings
Values screenFAIL · score 10.0
Beta0.07
The Workings

Five Screens, Shown in Full

Does not pass. Debt ratio

TestFigureLimitWhat it meansStatus
Business activity Permissible Core business clean Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. Pass
Debt load 41.76% Below 33% Interest-bearing debt is 41.8% of its assets, above the one-third ceiling the screen allows. Fail
Interest-bearing cash 1.28% Below 33% Cash held in interest-bearing accounts and securities is 1.3% of assets, under the one-third limit. Pass
Receivables 12.05% Below 49% Money owed to the company is 12.0% of assets, under the 49% limit. Pass
Revenue purity 0.30% Below 5% Only 0.3% of revenue comes from non-compliant sources, under the 5% line. Pass

Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.

The Ethical Read

Why It Falls Short, in Plain English

Hershey Company (The)'s business is in a permissible area, but its interest-bearing debt is about 42% of the company, well over the ~33% line, so it does not pass on the financial screens.

Read as at 2026-11-15. It updates when the underlying figures move, and past reads are kept below.

Follow this verdict

Get an email when HSY's ethical verdict changes

Today HSY does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.

Free, no account needed. Every email has a link to stop.

What the Numbers Say It Is Worth

The Fair Value Range

Our analysis reads Overvalued vs our fair value, as of 13 Nov 2026: it trades above our $148.37 fair value estimate, narrow competitive moat, 3.00% revenue growth.

How a fair value is estimated: discounted cash flow (DCF).

138.60Conservative148.37Base case170.62Growth case 174.27Price

Fair value range in USD, drawn from the 2026-11-13 screen. The gold marker is the market price at the same screen. The price runs 17.5% above the base estimate.

The Street's Range
154.00Street low 173.00Street average 230.00Street high 174.27Price

Third-party analyst targets: 21 covering, consensus Hold. The average target sits −1% from the screen price.

Reading the gap · Both our model and the Street see limited upside at this price.

Price History & Projections

Where our models see it going: fair-value estimate $148.37, with a range of $138.60 to $170.62, dated to the 2026-11-13 screen.

Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.

The Business, in Plain Words

Sweet bars cannot hide rising debt

A Hershey bar still sells at the checkout counter, yet the balance sheet reveals debt levels that fail our ethical screen outright. We pass on the name despite 11% revenue growth, a 23% ROE and a forward P/E of 17.3x. The narrow moat and analyst target of 208 do not offset the debt ratio breach.

Risk sits in the leverage itself, which leaves little room for cocoa price spikes or margin pressure at the current 9% profit margin. Even with an 18% gap to our fair value the ethical failure rules it out.

Analysis, not advice.

The fundamentals · plain-English read
Forward P/E18.4xexpensive even after accounting for its growth
Trailing P/E19.7xreasonably valued
EPS, trailing8.84
EPS, forward9.48
Revenue growth+3.0%slow but positive growth
Profit margin14.6%thin but positive margins
Return on equity38.0%an exceptional return on shareholder capital
FCF yield4.78%
Dividend yield2.98%
Debt to equity1.11a meaningful debt load worth watching
Current ratio1.24adequate liquidity, worth monitoring
Beta0.07barely tracks the market's swings
Short interest, float0.07%
52-week range156.16 - 239.48
MoatNARROW
Market cap$35.0B
Employees17,550

Another profit measure, before interest, tax and non-cash costs: EBITDA.

The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.

Plain-English interpretation of our own screen data. Analysis, not advice.

Where & How to Trade

HSY trades on a US exchange. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.

The Dated Journal · Newest First, Never Edited

Every Entry, As Written

2026-11-12 Markup $176.43 +1.1% Entry 18

The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 1.1% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading bullish. Over the past year the shares are up 8%. Our forward projection puts the odds of a 10% gain over the next month near 14%. The street (23 analysts) rates it hold, with a mean price target of $217. Since the last review it its composite score eased.

2026-11-05 Markup $174.50 +2.9% Entry 17

The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 2.9% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading bullish. Over the past year the shares are up 8%. Our forward projection puts the odds of a 10% gain over the next month near 14%. The street (23 analysts) rates it hold, with a mean price target of $217.

2026-10-29 Markup $169.64 +0.6% Entry 16

The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 0.6% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading bullish. Over the past year the shares are up 8%. Our forward projection puts the odds of a 10% gain over the next month near 14%. The street (23 analysts) rates it hold, with a mean price target of $217. It reported earnings in this window, a natural checkpoint for the thesis.

2026-10-28 Markup $168.68 +0.0% Entry 15

The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading bullish. Over the past year the shares are up 8%. Our forward projection puts the odds of a 10% gain over the next month near 14%. The street (23 analysts) rates it hold, with a mean price target of $217. It reported earnings in this window, a natural checkpoint for the thesis.

2026-10-27 Markup $168.68 +0.0% Entry 14

The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading bullish. Over the past year the shares are up 8%. Our forward projection puts the odds of a 10% gain over the next month near 14%. The street (23 analysts) rates it hold, with a mean price target of $217. It reported earnings in this window, a natural checkpoint for the thesis.

2026-10-26 Markup · changed $168.68 +0.0% Entry 13

The framework has shifted from accumulation to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading bullish. Over the past year the shares are up 8%. Our forward projection puts the odds of a 10% gain over the next month near 14%. The street (23 analysts) rates it hold, with a mean price target of $217. It reported earnings in this window, a natural checkpoint for the thesis.

2026-10-25 Accumulation $168.68 +0.0% Entry 12

The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading bullish. Over the past year the shares are up 8%. Our forward projection puts the odds of a 10% gain over the next month near 14%. The street (23 analysts) rates it hold, with a mean price target of $217. It reported earnings in this window, a natural checkpoint for the thesis.

2026-10-24 Accumulation $168.68 +0.0% Entry 11

The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading bullish. Over the past year the shares are up 8%. Our forward projection puts the odds of a 10% gain over the next month near 14%. The street (23 analysts) rates it hold, with a mean price target of $217. It reported earnings in this window, a natural checkpoint for the thesis.

2026-10-23 Accumulation $168.68 +0.0% Entry 10

The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading bullish. Over the past year the shares are up 8%. Our forward projection puts the odds of a 10% gain over the next month near 14%. The street (23 analysts) rates it hold, with a mean price target of $217. It reported earnings in this window, a natural checkpoint for the thesis.

2026-10-22 Accumulation $168.68 +0.0% Entry 9

The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading bullish. Over the past year the shares are up 8%. Our forward projection puts the odds of a 10% gain over the next month near 14%. The street (23 analysts) rates it hold, with a mean price target of $217. It reported earnings in this window, a natural checkpoint for the thesis.

Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.

Latest News · What the Market Is Reading on HSY

Headlines from third-party outlets, linked for reference: not our reporting, not advice.

Related Securities · Others in HSY's Space

Screened names in the same industry · explore each on its own page.

The Insider Ledger · Form 4 Filings, As Filed
Most recent filings · HSY
DateInsiderTitleTypeSharesValue
2026-10-29 Hershey Trust Co Trustee In Trust For Milton Hershey School 10% S - Sale+OE 20,000 $3,264,345
2026-10-26 Hershey Trust Co Trustee In Trust For Milton Hershey School 10% S - Sale+OE 30,000 $4,955,173
2026-10-22 Hershey Trust Co Trustee In Trust For Milton Hershey School 10% S - Sale+OE 20,000 $3,449,176
2026-10-12 Hershey Trust Co Trustee In Trust For Milton Hershey School 10% S - Sale+OE 30,000 $4,899,327
2026-10-08 Hershey Trust Co Trustee In Trust For Milton Hershey School 10% S - Sale+OE 20,000 $3,247,111
2026-10-05 Hershey Trust Co Trustee In Trust For Milton Hershey School 10% S - Sale+OE 30,000 $4,826,849
2026-09-28 Hershey Trust Co Trustee In Trust For Milton Hershey School 10% S - Sale+OE 30,000 $4,855,338
2026-09-24 Hershey Trust Co Trustee In Trust For Milton Hershey School 10% S - Sale+OE 20,000 $3,344,625
2026-05-20 HERSHEY TRUST CO Beneficial Owner of more than 10% of a Class of Security 30,000 $5,747,625
2026-05-18 VOSKUIL STEVEN E Chief Financial Officer 1,500 $279,375

Public filings, recorded as found. The full tape lives at Insider Intelligence.

The Political Ledger · Congressional Disclosures
Disclosures naming HSY
DatePoliticianPartyTypeAmount
2026-10-07 Ro Khanna Democrat sell 1K–15K
2026-09-04 Ro Khanna Democrat buy 1K–15K
2026-09-04 Ro Khanna Democrat buy 1K–15K
2024-05-03 Tommy Tuberville Republican sell 1K–15K
What Holding Actually Paid · Price Plus Dividends
If $1,000 had been placed · historical, not a promise
PeriodPrice thenPrice returnDivs per share$1,000 becameTotal return
1 month $187.79 -5.8% $1.45 $950 -5.0%
2 months $200.77 -11.8% $1.45 $889 -11.1%
3 months $213.86 -17.2% $1.45 $834 -16.6%
6 months $179.02 -1.1% $2.90 $1,005 +0.5%
1 year $163.64 +8.2% $5.64 $1,116 +11.6%
2 years $179.72 -1.5% $11.12 $1,047 +4.7%
3 years $234.53 -24.5% $16.25 $824 -17.6%
5 years $154.54 +14.5% $24.00 $1,301 +30.1%

Historical returns from market close data. Past performance does not guarantee future results.

The Ledger's Promise

This entry now belongs to the ledger. Whatever HSY does next, these words stay.

Hershey Company (The) · HSY · Markup · $174.27
Recorded 2026-11-13 · before the outcome · scored mechanically

Membership

Thirteen thousand names carry this page. One desk keeps them honest.

Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.

Join the desk

Screening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.

Get our weekly market brief free.